Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The global rating for each article was based on the following grading system: strong (no weak ratings); moderate (one weak rating) and weak (two or more weak ratings).
References
Albrecht, S., Semrau, K., Kasonde, P., Sinkala, M., Kankasa, C., Vwalika, C., Aldrovandi, G. M., Thea, D. M., & Kuhn, L. (2006). Predictors of nonadherence to single-dose nevirapine therapy for the prevention of mother-to-child HIV transmission. Journal of Acquired Immune Deficiency Syndromes, 41, 114–118.
Armstrong, R., Waters, E., Jackson, N., Oliver, S., Popay, J., & Shepherd, J. (2007). Guidelines for systematic reviews of health promotion and public health interventions. Version 2. Melbourne University.
Bardeguez, A. D., Lindsey, J. C., Shannon, M., Tuomala, R. E., Cohn, S. E., Smith, E., Stek, A., Buschur, S., Cotter, A., Bettica, L., Read, J. S., & Team, P. P. (2008). Adherence to antiretrovirals among US women during and after pregnancy. Journal of Acquired Immune Deficiency Syndrome, 48, 408–417.
Battaglioli-Denero, A. M. (2007). Strategies for improving patient adherence to therapy and long-term patient outcomes. Journal of the Association of Nurses in AIDS Care, 18, S17–22.
Bii, S. C., Otieno-Nyunya, B., Siika, A., & Rotich, J. K. (2007). Self-reported adherence to single dose nevirapine in the prevention of mother to child transmission of HIV at Kitale District Hospital. East African Medical Journal, 84, 571–576.
CASP. (2011). Critical Appraisal Skills Programme [Online]. CASP. Available: http://media.wix.com/ugd/dded87_29c5b002d99342f788c6ac670e49f274.pdf. Accessed July 2011.
Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care STDS, 17, 169–177.
Ciambrone, D., Loewenthal, H. G., Bazerman, L. B., Zorilla, C., Urbina, B., & Mitty, J. A. (2006). Adherence among women with HIV infection in Puerto Rico: The potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women. Women and Health, 44, 61–77.
Cohn, S. E., Umbleja, T., Mrus, J., Bardeguez, A. D., Andersen, J. W., & Chesney, M. A. (2008). Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: Adherence analysis A5084. AIDS Patient Care and STDs, 22, 29–40.
Delvaux, T., Elul, B., Ndagije, F., Munyana, E., Roberfroid, D., & Asiimwe, A. (2009). Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda. Journal of Acquired Immune Deficiency Syndromes, 50, 223–230.
Demas, P. A., Thea, D. M., Weedon, J., McWayne, J., Bamji, M., Lambert, G., & Schoenbaum, E. E. (2005). Adherence to zidovudine for the prevention of perinatal transmission in HIV-infected pregnant women: The impact of social network factors, side effects, and perceived treatment efficacy. Women and Health, 42, 99–115.
Dimatteo, M. R., Haskard, K. B., & Williams, S. L. (2007). Health beliefs, disease severity, and patient adherence: A meta-analysis. Medical Care, 45, 521–528.
Duff, P., Kipp, W., Wild, T. C., Rubaale, T., & Okech-Ojony, J. (2010). Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. Journal of the International AIDS Society, 13, 37.
El-Khatib, Z., Ekstrom, A. M., Coovadia, A., Abrams, E. J., Petzold, M., Katzenstein, D., Morris, L., & Kuhn, L. (2011). Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa—A prospective cohort study. BMC Public Health, 11, 88.
Higgins, J., & Green, S. (2011). Cochrane handbook for systematic reviews of interventions version 5.1. 0: The cochrane collaboration; 2011 [updated March 2011]. Available from: www.cochrane-handbook.org.
Ickovics, J. R., Wilson, T. E., Royce, R. A., Minkoff, H. L., Fernandez, M. I., Fox-Tierney, R., Koenig, L. J., & Perinatal Guidelines Evaluation, G. (2002). Prenatal and postpartum zidovudine adherence among pregnant women with HIV: Results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. Journal of Acquired Immune Deficiency Syndromes, 30, 311–315.
Kapetanovic, S., Christensen, S., Karim, R., Lin, F., Mack, W. J., Operskalski, E., Frederick, T., Spencer, L., Stek, A., Kramer, F., & Kovacs, A. (2009). Correlates of perinatal depression in HIV-infected women. AIDS Patient Care and STDs, 23, 101–108.
Kirsten, I., Sewangi, J., Kunz, A., Dugange, F., Ziske, J., Jordan-Harder, B., Harms, G., & Theuring, S. (2011). Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania. PLoS One, 6, e21020.
Laine, C., Newschaffer, C. J., Zhang, D., Cosler, L., Hauck, W. W., & Turner, B. J. (2000). Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: A pharmacy claims-based analysis. Obstetrics and Gynecology, 95, 167–173.
Leigh, B., & Milgrom, J. (2008). Risk factors for antenatal depression, postnatal depression and parenting stress. BMC Psychiatry, 8, 24.
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine, 6, e1000100.
McDonald, K., & Kirkman, M. (2011). HIV-positive women in Australia explain their use and non-use of antiretroviral therapy in preventing mother-to-child transmission. AIDS Care, 23, 578–584.
Mellins, C. A., Chu, C., Malee, K., Allison, S., Smith, R., Harris, L., Higgins, A., Zorrilla, C., Landesman, S., Serchuck, L., & Larussa, P. (2008). Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care, 20, 958–968.
Mepham, S., Zondi, Z., Mbuyazi, A., Mkhwanazi, N., & Newell, M. L. (2011). Challenges in PMTCT antiretroviral adherence in northern KwaZulu-Natal, South Africa. AIDS Care, 23, 741–747.
Nachega, J. B., Uthman, O. A., Anderson, J., Peltzer, K., Wampold, S., Cotton, M. F., Mills, E. J., Ho, Y. S., Stringer, J. S., McIntyre, J. A., & Mofenson, L. M. (2012). Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: A systematic review and meta-analysis. AIDS, 26, 2039–2052.
Nel, A., & Kagee, A. (2013). The relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in South Africa. AIDS Care, 25, 948–955.
Peltzer, K., Mlambo, M., Phaswana-Mafuya, N., & Ladzani, R. (2010). Determinants of adherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Gert Sibande district in South Africa. Acta Paediatrica, 99, 699–704.
Peltzer, K., Sikwane, E., & Majaja, M. (2011). Factors associated with short-course antiretroviral prophylaxis (dual therapy) adherence for PMTCT in Nkangala district, South Africa. Acta Paediatrica, 100, 1253–1257.
Poppa, A., Davidson, O., Deutsch, J., Godfrey, D., Fisher, M., Head, S., Horne, R., Sherr, L., British, H. I. V. A., & British Association for Sexual, H., & HIV. (2004). British HIV Association (BHIVA)/British Association for Sexual Health and HIV (BASHH) guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003). HIV Medicine, 5(Suppl 2), 46–60.
Rich-Edwards, J. W., Kleinman, K., Abrams, A., Harlow, B. L., McLaughlin, T. J., Joffe, H., & Gillman, M. W. (2006). Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice. Journal of Epidemiology and Community Health, 60, 221–227.
Simek, E., McPhate, L., & Haines, T. (2012). Adherence to and efficacy of home exercise programs to prevent falls: A systematic review and meta-analysis of the impact of exercise program characteristics. Preventive Medicine, 55, 262–275.
Turner, B. J., Newschaffer, C. J., Zhang, D., Cosler, L., & Hauck, W. W. (2000). Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Medical Care, 38, 911–925.
Vaz, M. J., Barros, S. M., Palacios, R., Senise, J. F., Lunardi, L., Amed, A. M., & Castelo, A. (2007). HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women. International Journal of STD and AIDS, 18, 28–32.
Vyavaharkar, M., Moneyham, L., Tavakoli, A., Phillips, K. D., Murdaugh, C., Jackson, K., & Meding, G. (2007). Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States. AIDS Patient Care and STDs, 21, 667–680.
WHO. (2010). Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Recommendations for a public health approach. WHO.
Wilson, T. E., Ickovics, J. R., Fernandez, M. I., Koenig, L. J., Walter, E., & Perinatal Guidelines Evaluation, P. (2001). Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states. American Journal of Obstetrics and Gynecology, 184, 1235–1240.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Vitalis, D. (2021). Systematic Review of the Literature. In: Adherence to Antiretroviral Therapy among Perinatal Women in Guyana. Palgrave Macmillan, Singapore. https://doi.org/10.1007/978-981-15-3974-9_2
Download citation
DOI: https://doi.org/10.1007/978-981-15-3974-9_2
Published:
Publisher Name: Palgrave Macmillan, Singapore
Print ISBN: 978-981-15-3973-2
Online ISBN: 978-981-15-3974-9
eBook Packages: MedicineMedicine (R0)